Migraine Medications: Essential Guide For Acute, Preventive Care
Explore effective treatments for migraine relief and prevention, from triptans to innovative gepants and ditans.

Migraine medications target both immediate symptom relief during attacks and long-term prevention to reduce frequency. Acute treatments focus on stopping pain and associated symptoms quickly, while preventive options aim to lessen attack severity and occurrence over time.
Understanding Acute Migraine Treatments
Acute therapies are taken at the onset of a migraine to alleviate pain, nausea, and sensitivity to light or sound. These include over-the-counter options, targeted prescription drugs, and newer classes developed to address limitations of older medications.
Non-Specific Pain Relievers
Simple analgesics form the first line for mild migraines. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen (200-800 mg), naproxen (550-1100 mg daily in divided doses), and aspirin (up to 1000 mg) reduce inflammation and pain. These are affordable and widely available but may fail for moderate to severe attacks or cause gastrointestinal issues with overuse.
- Ibuprofen: Effective for early intervention; avoid in stomach ulcer history.
- Naproxen: Longer-lasting relief, ideal for prolonged episodes.
- Aspirin: Often combined with other agents for enhanced effect.
Acetaminophen serves as an alternative for those unable to take NSAIDs, though evidence for migraines is weaker and liver risks exist in high doses.
Triptans: The Established Standard
Triptans, serotonin receptor agonists, constrict blood vessels and block pain pathways in the brain. Seven FDA-approved options exist: sumatriptan (25-100 mg oral, nasal spray), eletriptan (20-40 mg), frovatriptan (2.5 mg), naratriptan, rizatriptan, zolmitriptan, and almotriptan. A network meta-analysis of 64 trials with over 46,000 participants showed triptans generally outperform placebo for 2-hour pain freedom, with eletriptan 40 mg (OR 5.59) and rizatriptan 10 mg excelling.
Eletriptan and rizatriptan rank highest in efficacy for oral forms, while almotriptan offers a favorable side effect profile. Common forms include tablets, nasal sprays, and injections for faster action. Contraindications include cardiovascular disease due to vasoconstriction risks.
| Triptan | Dose Range | Key Strength |
|---|---|---|
| Eletriptan | 20-40 mg | High pain freedom rates |
| Rizatriptan | 5-10 mg | Fast relief, high OR for pain relief |
| Frovatriptan | 2.5 mg | Longest duration |
| Sumatriptan | 25-100 mg oral | Multiple delivery options |
Ergotamines and Derivatives
Dihydroergotamine (DHE), available as nasal spray (2-3 mg) or injection, provides sustained relief for prolonged migraines. It activates serotonin receptors similarly to triptans but with longer action. Use cautiously in those with vascular issues.
Next-Generation Targeted Therapies
Recent advancements address triptan limitations, such as cardiovascular contraindications and inconsistent efficacy. Ditans and gepants offer alternatives without vasoconstriction.
Ditans: Lasmiditan
Lasmiditan, a 5-HT1F receptor agonist (50-200 mg oral), was FDA-approved in 2019 for acute treatment. It relieves pain without vascular effects, suiting patients with heart risks. Trials show pain freedom at 2 hours superior to placebo (OR 1.65- higher doses), though less than most triptans. Dizziness is common, limiting driving post-dose.
Gepants: CGRP Antagonists
Calcitonin gene-related peptide (CGRP) inhibitors block migraine-triggering pathways. Ubrogepant (oral tablet) and rimegepant (orally dissolving tablet) provide acute relief with ORs for pain freedom better than placebo but below top triptans. Rimegepant and ubrogepant have lower adverse event risks than lasmiditan or some triptans.
- Ubrogepant: Flexible dosing for attacks.
- Rimegepant: Dual use for acute and prevention (every other day).
Atogepant focuses on prevention.
Preventive Migraine Strategies
For frequent or debilitating migraines (4+ per month), preventives reduce attack frequency by 50% or more. Options span antidepressants, antiepileptics, beta-blockers, and CGRP therapies.
Traditional Preventives
Topiramate (25-200 mg/day) and valproate (500-1500 mg/day) are evidence-based antiepileptics. Amitriptyline (10-25 mg nightly), a tricyclic antidepressant, boosts serotonin and norepinephrine; side effects include drowsiness and dry mouth.
- Propranolol: Beta-blocker for vascular stability.
- Venlafaxine: SNRI alternative with fewer sedating effects.
Modern CGRP Preventives
Atogepant and rimegepant (preventive dosing) offer oral gepant options with fewer systemic effects. Monoclonal antibodies like erenumab (injections) target CGRP but are beyond oral meds scope here.
| Drug Class | Examples | Dosing | Common Side Effects |
|---|---|---|---|
| Antiepileptics | Topiramate | 25-200 mg/day | Weight loss, cognitive issues |
| Antidepressants | Amitriptyline | 10-25 mg nightly | Dry mouth, sedation |
| Gepants (Prev.) | Rimegepant | Every other day | Nausea, constipation |
Comparing Treatment Efficacy and Safety
Triptans lead in 2-hour pain freedom (e.g., rizatriptan OR 9.19 for relief), followed by gepants and ditans. Lasmiditan carries highest adverse event risk (OR up to 9.66), including dizziness; gepants are safest among specifics. Combinations like sumatriptan-naproxen boost efficacy.
For clinical use, select based on patient profile: triptans for healthy adults, gepants/ditans for cardiac risks.
Practical Considerations for Use
Start acute meds early. Limit triptans to 2-3 days/week to avoid medication-overuse headache. Track triggers and response in a diary. Consult providers for pregnancy, as many are contraindicated.
Frequently Asked Questions
What is the best first-line acute migraine drug?
NSAIDs or acetaminophen for mild cases; triptans like eletriptan for severe.
Are gepants better than triptans?
Triptans often superior in efficacy, but gepants safer for heart patients.
Can I drive after lasmiditan?
No, due to dizziness; avoid for 8 hours.
How do preventives work?
They stabilize brain excitability, reducing attack frequency.
What if meds fail?
Consider neuromodulation devices or specialist referral.
References
- Comparison of New Pharmacologic Agents With Triptans for Acute Treatment of Migraine — JAMA Network Open. 2023-02-01. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784777
- Migraine Treatments | What Options Do You Have? — Migraine Disorders Association. 2024-01-15. https://www.migrainedisorders.org/migraine-disorders/migraine-treatments/
- Migraine Medications – StatPearls — NCBI Bookshelf. 2023-10-20. https://www.ncbi.nlm.nih.gov/books/NBK553159/
- Treatment of migraine attacks and prevention of migraine — International Headache Society. 2020-06-01. https://ihs-headache.org/wp-content/uploads/2020/06/3426_dmkg-treatment-of-migraine-attacks-and-prevention-of-migraine.pdf
- Migraine – Diagnosis and treatment — Mayo Clinic. 2024-05-10. https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360207
Read full bio of medha deb
















